Platelet-activation and Optimal Inhibition in Patients With Atrial Fibrillation Undergoing Left Atrial Appendage Occlusion
POPULAR-LAAO
POPULAR-LAAO
Sponsor study identifier
observational
120
1 country
1
Study Start
February 24, 2021
Actual (reported)Primary Completion
December 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The POPULAR-LAAO registry is an open-label observational prospective registry to investigate hemostatic processes following left atrial appendage occlusion.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 22, 2020
Actual (reported)January 12, 2021
Actual (reported)February 24, 2021
Actual (reported)December 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
December 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Change in coagulation activation
Influence of LAAO on coagulation activation over time
Pre-LAAO and post-LAAO (1 day, 2 weeks, 3 months, 6 months)
Change in platelet reactivity
Influence of LAAO on platelet reactivity over time
Pre-LAAO and post-LAAO (1 day, 2 weeks, 3 months, 6 months)
CYP2C19 genotype
Rate of clopidogrel non-responders among LAAO patients will be assessed by determining CYP2C19 genotype
Pre-LAAO
Separate and composite event rates of stroke (ischemic or hemorrhagic), transient ischemic attack (TIA), systemic embolism and cardiovascular death.
Post-LAAO (3 months, 6 months, 12 months)
Major and minor bleeding event rate (according to Bleeding Academic Research Consortium criteria)
Post-LAAO (3 months, 6 months, 12 months)
Device related thrombus event rate
Post-LAAO (3 months, 12 months)
Patients undergoing left atrial appendage occlusion.
The study population will consist of patients with non-valvular AF at high risk for cardio-embolic stroke scheduled for left atrial appendage occlusion.
St. Antonius Ziekenhuis
Nieuwegein, Utrecht, 3430 EM, Netherlands
Blood samples will be preserved for analysis of hemostatic markers and CYP2C19 genotyping.
Lucas VA Boersma, MD PhD
St. Antonius Hospital
First Submitted
December 22, 2020
First Posted
January 12, 2021
Study Start
February 24, 2021
Actual (reported)Primary Completion
December 2024
Estimated (date passed)A Trial Evaluating the Safety and Effectiveness of the Laminar Left Atrial Appendage Closure System in Subjects With Non-Valvular Atrial Fibrillation
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
March 12, 2021
Record last verified: 2021-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: